Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Investigating the potential of mutation load detection and a mismatch repair functional assay as diagnostic tools for the fatal pediatric cancer Biallelic Mismatch Repair Deficiency Syndrome

EF 2016-17

Résumé
Biallelic mismatch repair deficiency syndrome (BMMRD) is a childhood disease causing brain, gastrointestinal and blood cancers, and most patients do not survive into adulthood. BMMRD is caused by complete loss of function of the process that repairs DNA mismatches. An accurate diagnostic tool for BMMRD has not yet been developed, preventing patients from receiving timely treatment. Previously proposed diagnostic tools have led to many false-negative and false-positive diagnoses, and thus a reliable diagnostic tool is desperately needed. I will investigate two new techniques with strong diagnostic potential to determine if they can reliably detect BMMRD. Our group has shown that BMMRD cancers have extremely high numbers of mutations surpassing that reported for other cancers. I will measure mutation levels in BMMRD patient normal cells using Next Generation Sequencing to see if BMMRD normal tissue also has these high mutation levels, which would allow mutation abundance analysis of normal cells to be used to diagnose BMMRD prior to cancer onset. This will also identify mutations specific to BMMRD patient normal cells which can be used for diagnosis. In addition, I will transfect BMMRD patient normal cells with Enhanced Green Fluorescent Protein plasmids containing a mismatch and detect fluorescence to measure mismatch repair (MMR) to determine the potential of this technique to identify defective MMR. Lack of MMR in all tested BMMRD patient normal cells will validate this technique for identifying defective MMR, and thus for diagnosing BMMRD. If these techniques prove successful at identifying BMMRD, they can be universally implemented for accurate diagnosis, ensuring patients receive appropriate treatment and increasing survival.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
367183
Name
Kelly Jacalyn A
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating the potential of mutation load detection and a mismatch repair functional assay as diagnostic tools for the fatal pediatric cancer Biallelic Mismatch Repair Deficiency Syndrome
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Biallelic Mismatch Repair Deficiency Syndrome; Brain Cancer; Diagnostics; Functional Assay; Gastrointestinal Cancer; Mismatch Repair Deficiency; Next Generation Sequencing; Pediatrics; Plasmid Cloning; Ultra-Hypermutation
Abstract
Biallelic mismatch repair deficiency syndrome (BMMRD) is a childhood disease causing brain, gastrointestinal and blood cancers, and most patients do not survive into adulthood. BMMRD is caused by complete loss of function of the process that repairs DNA mismatches. An accurate diagnostic tool for BMMRD has not yet been developed, preventing patients from receiving timely treatment. Previously proposed diagnostic tools have led to many false-negative and false-positive diagnoses, and thus a reliable diagnostic tool is desperately needed. I will investigate two new techniques with strong diagnostic potential to determine if they can reliably detect BMMRD. Our group has shown that BMMRD cancers have extremely high numbers of mutations surpassing that reported for other cancers. I will measure mutation levels in BMMRD patient normal cells using Next Generation Sequencing to see if BMMRD normal tissue also has these high mutation levels, which would allow mutation abundance analysis of normal cells to be used to diagnose BMMRD prior to cancer onset. This will also identify mutations specific to BMMRD patient normal cells which can be used for diagnosis. In addition, I will transfect BMMRD patient normal cells with Enhanced Green Fluorescent Protein plasmids containing a mismatch and detect fluorescence to measure mismatch repair (MMR) to determine the potential of this technique to identify defective MMR. Lack of MMR in all tested BMMRD patient normal cells will validate this technique for identifying defective MMR, and thus for diagnosing BMMRD. If these techniques prove successful at identifying BMMRD, they can be universally implemented for accurate diagnosis, ensuring patients receive appropriate treatment and increasing survival.
Competitiondate
201612
Approvedterm2
1 yr 0 mth
Pinamesdelim
Kelly, Jacalyn A
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~